Product Information

CINACALCET HCL 30 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.4190 per EA under NDC 60687051621. Its NADAC has been published 72 times since Jul 2, 2025.

FDA first approved this application on Apr 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Cinacalcet market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CINACALCET HCL 30 MG TABLET

Cinacalcet
$0.4190per EA
Low Outlier

Strength

30 mg/1

NDC

60687051621

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CINACALCET HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209226

FDA Approved

4/30/2018

TE Code

AB

On Market Since

5/18/2025

Pharmacological Classes

Calcium-sensing Receptor Agonist
Increased Calcium-sensing Receptor Sensitivity

Price Statistics

The NADAC for CINACALCET HCL 30 MG TABLET has been published 72 times since Jul 2, 2025, and over the history we have for it it has risen 17.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4190 per EA
All-time high$0.4190 (Nov 11, 2026)
All-time low$0.3448 (Aug 20, 2025)
52-week high$0.4190
52-week low$0.3953
Median price$0.4022
Average price$0.3926
Largest weekly change+7.2% (Nov 19, 2025)
Weeks tracked72
Tracking sinceJul 2, 2025

Price History

1W

0.0%

1M

+1.8%

3M

+6.0%

6M

+5.4%

1Y

+10.6%

3Y

N/A

5Y

N/A

All

+17.2%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CINACALCET HCL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CINACALCET HCL 30 MG TABLET, manufactured by American Health Packaging, is $0.4190 per EA (NDC 60687051621), effective Nov 11, 2026.

How has the price of CINACALCET HCL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for CINACALCET HCL 30 MG TABLET has risen 17.2%. It has been tracked across 72 weekly CMS publications since Jul 2, 2025.

What are the highest and lowest recorded NADAC prices for CINACALCET HCL 30 MG TABLET?

Since Jul 2, 2025, the NADAC for CINACALCET HCL 30 MG TABLET has ranged from a low of $0.3448 (Aug 20, 2025) to a high of $0.4190 (Nov 11, 2026), with a median of $0.4022 per EA.

Are there cheaper alternatives to CINACALCET HCL 30 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CINACALCET HCL 30 MG TABLET, is $0.4030 per EA — about 4% below CINACALCET HCL 30 MG TABLET.

Who manufactures CINACALCET HCL 30 MG TABLET?

CINACALCET HCL 30 MG TABLET (NDC 60687051621) is labeled by American Health Packaging, and CMS classifies it as a generic product.